Abstract
Invention relates to a method for detection of risk of development of skin neoplastic damage caused by damage resulted from free radicals. The risk exists if three or more keratosis zones together with six or more gravitational wrinkles combined with three or more lentigo zones or alternatively three or more keratosis zones together with six or more gravitational wrinkles in combination with set of 40% teleangietic areas are detected in combination with serum content of 3.650 mmol/L or more malondialdehyde (MDA) having 1780 U/g acitivity of superoxide dismutase (SOD).
Translated title of the contribution | Ādas neoplastisko bojājumu, ko izraisa brīvo radikāļu bojājumi, attīstības riska noteikšanas paņēmiens |
---|---|
Original language | Latvian |
Patent number | 15405 |
IPC | A61B1/00,G01N33/50 |
Priority date | 29/01/19 |
Filing date | 29/01/19 |
Publication status | Published - 20 Aug 2020 |
Keywords*
- skin neoplastic damage
Field of Science*
- 3.2 Clinical medicine
Patent expiration date
- 31.07.2023